ÍÃ×ÓÏÈÉú

[Sponsored] While over 90% of inpatient admits in the US have a peripheral intravenous catheter (PIV) inserted, the rate of failure has been reported between 36% and 63%1, which can lead to significant delays in therapy and more importantly, costly IV restarts. These PIV failures are largely the result of mechanical complications. This randomized controlled trial evaluates a novel Force-Activated Separation Device (FASD) to determine its impact on PIV complication rates and delays in infusion therapy.

Sponsored By

ÍÃ×ÓÏÈÉúdoes not support or endorse connections products or services.